The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Jacob S. Ballon, MD, MPH,1 Christina Arevalo, MS,2 Shifang Liu, PhD,2 Christoph U. Correll, MD3-7
1Stanford University, Department of Psychiatry, Stanford, CA, USA; 2Alkermes, Inc., Waltham, MA, USA; 3Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; 4Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany; 5The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; 6Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Northwell Health, New Hyde Park, NY, USA; 7German Center for Mental Health (DZPG), partner site Berlin, Germany
